Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Cardiac Pathways

1991 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
$115M LATEST DEAL AMOUNT
Description

Provider of invasive systems used by electrophysiologists to diagnose and treat abnormally rapid heart rhythms. The company's products consist of systems for performing nonsurgical, minimally invasive techniques for neutralizing heart tissues responsible for starting tachyarrhythmia.

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Acquirer
Boston Scientific
Primary Office
  • 995 Benecia Avenue
  • Sunnyvale, CA 94085
  • United States

+1 (408) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Cardiac Pathways’s full profile, request a free trial.

Cardiac Pathways Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Merger/Acquisition 06-Aug-2001 $115M 00000 00000 Completed Generating Revenue
8. PIPE 26-Dec-2000 000.00 00000 Completed Generating Revenue
7. IPO 01-Jun-1996 000.00 000.00 Completed Startup
6. Later Stage VC (Series F) 01-Dec-1995 000.00 000.00 000.00 Completed Startup
5. Later Stage VC (Series E) 16-May-1994 00.00 000.00 000.00 Completed Startup
4. Later Stage VC (Series D) 29-Oct-1993 0000 000.00 000.00 Completed Startup
3. Later Stage VC (Series C) 00.000 000.00 000.00 Completed Startup
2. Early Stage VC (Series B) $3.41M $3.95M 00.000 Completed Startup
1. Early Stage VC (Series A) $533K $538K 00.000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Cardiac Pathways Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series F 000,000 00.000000 00.0 000 000 00 000 00.000
Series E 000,000 00.000000 00.00 000.00 000.00 00 000.00 0.000
Series D 0,000,000 00.000000 00.00 00.0 00.0 00 00.0 00.00
Series C 0,000,000 00.000000 00.00 00 00 00 00 00.000
Series B 1,514,445 $0.001000 $0.18 $2.25 $2.25 1x $2.25 23.02%
Series A 716,667 $0.001000 $0.06 $0.75 $0.75 1x $0.75 10.79%
To view this company’s complete Cap Table, request access »

Cardiac Pathways Former Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
AWM Investment Hedge Fund Minority 000 0000 000000 0
Delphi Ventures Venture Capital Minority 000 0000 000000 0
Faria Fund Minority 000 0000 000000 0
Fogarty Family Revocable Trust Minority 000 0000 000000 0
IVP Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 13 investors. Get the full list »

Cardiac Pathways Executive Team (3)

Name Title Board
Seat
Contact
Info
Thomas Prescott President & Chief Executive Officer
Joseph Gorman Chief Investment Officer
Mir Imran Founder & Director